⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL292227 | 0.75 | — | — | |
| SCHEMBL291164 | 0.69 | — | — | |
| SCHEMBL23624 | 0.69 | — | — | |
| SCHEMBL1741456 | 0.69 | — | — | |
| SCHEMBL15791944 | 0.67 | — | — | |
| SCHEMBL972050 | 0.67 | — | — | |
| SCHEMBL127175 | 0.67 | — | — | |
| SCHEMBL9158244 | 0.67 | — | — | |
| SCHEMBL2051368 | 0.67 | — | — | |
| SCHEMBL6487194 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043688-B2 | Nickel catalysts with two alkali ions for homopolymerization and copolymerization | UNIVERSITY OF HOUSTON SYSTEM (US) | 2024-07-23 | — | — | US | disclosed |
| US-12043689-B2 | Nickel catalysts with single metal cations for homopolymerization and copolymerization | UNIVERSITY OF HOUSTON SYSTEM (US) | 2024-07-23 | — | — | US | disclosed |
| EP-4374928-A2 | NOVEL ALK2 INHIBITORS AND METHODS FOR INHIBITING BMP SIGNALING | The Brigham And Women's Hospital Inc. (US) | 2024-05-29 | — | — | EP | disclosed |
| US-20240166775-A1 | NICKEL CATALYSTS WITH TWO METAL CATIONS FOR HOMOPOLYMERIZATION AND COPOLYMERIZATION | UNIVERSITY OF HOUSTON SYSTEM (US) | 2024-05-23 | — | — | US | disclosed |
| WO-2024097972-A2 | COMPOUNDS AND METHODS FOR TREATING CANCERS | CEDARS-SINAI MEDICAL CENTER (US) | 2024-05-10 | — | — | WO | disclosed |
| EP-3484474-B1 | PHENOTHIAZINE COMPOUNDS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMOPATHIES | CHILDRENS MEDICAL CT CORP (US) | 2024-05-08 | — | — | EP | disclosed |
| US-20240117076-A1 | NICKEL CATALYSTS WITH SINGLE METAL CATIONS FOR HOMOPOLYMERIZATION AND COPOLYMERIZATION | UNIVERSITY OF HOUSTON SYSTEM (US) | 2024-04-11 | — | — | US | disclosed |
| US-11944625-B2 | Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2024-04-02 | — | — | US | disclosed |
| US-20240101727-A1 | NICKEL CATALYSTS WITH TWO ALKALI IONS FOR HOMOPOLYMERIZATION AND COPOLYMERIZATION | UNIVERSITY OF HOUSTON SYSTEM (US) | 2024-03-28 | — | — | US | disclosed |
| US-20240101726-A1 | NICKEL CATALYSTS WITH SINGLE ALKALI IONS FOR HOMOPOLYMERIZATION AND COPOLYMERIZATION | UNIVERSITY OF HOUSTON SYSTEM (US) | 2024-03-28 | — | — | US | disclosed |
| US-20020032175-A1 | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease | VERTEX PHARMACEUTICALS INCORPORATED | 2002-03-14 | — | — | US | disclosed |
| EP-0932617-B1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | VERTEX PHARMA (US) | 2002-01-16 | — | — | EP | disclosed |
| EP-1136498-A1 | Inhibitors of serine proteases, particularly hepatitis c virus NS3 protease | Vertex Pharmaceuticals Incorporated (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6265380-B1 | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease | VERTEX PHARMACEUTICALS INCORPORATED | 2001-07-24 | — | — | US | disclosed |
| EP-1066247-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | Vertex Pharmaceuticals Incorporated (US) | 2001-01-10 | — | — | EP | disclosed |
| CN-1238780-A | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease | VERTEX PHARMA (US) | 1999-12-15 | — | — | CN | disclosed |
| WO-1999050230-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1999-10-07 | — | — | WO | disclosed |
| EP-0932617-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | Vertex Pharmaceuticals Incorporated (US) | 1999-08-04 | — | — | EP | disclosed |
| WO-1998017679-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1998-04-30 | — | — | WO | disclosed |
| US-5003089-A | Preparation of cyclic 6-membered to 8-membered vinylene-1,2-dioxy compounds | BASF AKTIENGESELLSCHAFT (DE) | 1991-03-26 | — | — | US | disclosed |